The global Botanical Drug market was valued at US$ 33630 million in 2023 and is projected to reach US$ 43740 million by 2030, at a CAGR of 39.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug. This report contains market size and forecasts of Botanical Drug in global, including the following market information:
- Global Botanical Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2023 (%)
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
We surveyed the Botanical Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Botanical Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Botanical Drug Market Segment Percentages, by Type, 2023 (%)
Global Botanical Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Botanical Drug Market Segment Percentages, by Application, 2023 (%)
- Cardiovascular
- Tumor
- Respiratory System
- Others
Global Botanical Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Botanical Drug Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Botanical Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Botanical Drug revenues share in global market, 2023 (%)
key players include:
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Botanical Drug, market overview.
Chapter 2: Global Botanical Drug market size in revenue.
Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Botanical Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
